Early Improvement in Mitral Regurgitation after Cardiac Resynchronization Therapy in Cardiomyopathy Patients.

Authors:

Hakimeh Sadeghian Masoumeh Lotfi-Tokaldany Mahdi Montazeri Ali Kazemi Saeed Mohammad Sahebjam Akram Sardari Gita Ejmalian

J Heart Valve Dis 2017 09;26(5):557-563

Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.

Background: The study aim was to investigate factors affecting the improvement of mitral regurgitation (MR) severity within 48 hours after cardiac resynchronization therapy (CRT) in patients with cardiomyopathy.

Methods: Sixty-nine cardiomyopathy patients (48 males, 21 females; mean age 59.12 ± 9.66 years) in NYHA functional class ≥III, with left ventricular ejection fraction (LVEF) ≤35%, and QRS duration >120 ms, with MR ≥moderate, were included in the study. Conventional echocardiography was performed before and within 48 h after CRT, and all patients underwent tissue Doppler imaging prior to CRT. Improved MR was defined as a reduction of at least one grade in MR severity.

Results: After CRT, 49 patients (71%) showed MR improvement but 20 (29%) had no MR improvement. The mean MR severity grade was reduced significantly, from 2.70 ± 0.77 before CRT to 1.90 ± 0.94 after CRT (p<0.001). The group with improved MR had a significantly higher rate of left bundle branch block (75.5% versus 45%; p = 0.015), a higher QRS duration (172.00 ± 31.98 versus 147.25 ± 28.75 ms; p = 0.001), a higher median septal lateral delay (70 versus 35 ms, p = 0.035), and a higher median anteroseptal to posterior-wall delay by M mode (200 versus 130 ms, p = 0.041). Older age, longer QRS duration, and septallateral delay remained significant independent predictors of MR improvement. A greater proportion of patients with improved MR showed ≥5% increase in LVEF (55.1% versus 30.0%, p = 0.058).

Conclusions: CRT acutely reduced the severity of functional MR in the majority of cardiomyopathy patients. Those patients with improved MR showed a higher frequency of ≥5% increase in LVEF after CRT. Older age, longer QRS duration, and septallateral delay were independent predictors of MR improvement after CRT.

Download full-text PDF	Source

September 2017

Publication Analysis

Similar Publications

Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer.

Front Oncol 2021 18;11:626275. Epub 2021 Feb 18.

Radiation Oncology Department, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Purpose: To explore the feasibility and efficacy of a dose intensification with Intensity Modulated Radiation Therapy and Simultaneous Integrated Boost (IMRT-SIB) in locally advanced esophageal and gastroesophageal cancer (GEJ).

Methods And Materials: We retrospectively analyzed a series of 69 patients with esophageal or GEJ cancer treated at our Institute, between 2016 and 2019, with preoperative IMRT and SIB up to 52.5-54 Gy in 25 fractions in 5 weeks and concurrent carboplatin (AUC2) and paclitaxel (50 mg/m), as in the CROSS regimen. Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer.

J Immunother Cancer 2021 Mar;9(3)

Division of Molecular Pathology, Institute of Cancer Research, London, UK

Background: Rectal cancers show a highly varied response to neoadjuvant radiotherapy/chemoradiation (RT/CRT) and the impact of the tumor immune microenvironment on this response is poorly understood. Current clinical tumor regression grading systems attempt to measure radiotherapy response but are subject to interobserver variation. An unbiased and unique histopathological quantification method (change in tumor cell density (ΔTCD)) may improve classification of RT/CRT response. Read More

View Article and Full-Text PDF

March 2021

Similar Publications

Multipoint left ventricular pacing effects on hemodynamic parameters and functional status: HUMVEE single-arm clinical trial (NCT03189368).

Authors:

Christos-Konstantinos Antoniou Polychronis Dilaveris Christina Chrysohoou Konstantinos Konstantinou Nikolaos Magkas Panagiotis Xydis Panagiota Manolakou Ioannis Skiadas Konstantinos A Gatzoulis Dimitris Tousoulis Costas Tsioufis

Hellenic J Cardiol 2021 Mar 4. Epub 2021 Mar 4.

First Department of Cardiology, National and Kapodistrian University of Athens, Hippokrateion General Hospital, Athens, Greece.

Objectives: The aim of this study was to assess the capacity of optimized multipoint pacing (MPP) over optimized cardiac resynchronization therapy (CRT), in terms of clinical, functional, and echocardiographic parameters among dyssynchronous heart failure patients.

Methods: Eighty patients (Caucasian, 77.5% male, 68. Read More

View Article and Full-Text PDF

March 2021

Similar Publications

Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.

Authors:

Sylvie Bonvalot Jay Wunder Alessandro Gronchi Javier Martin Broto Robert Turcotte Marco Rastrelli Zsuzsanna Papai Stefano Radaelli Lars H Lindner Felix Shumelinsky Antonio Cubillo Piotr Rutkowski Clémentine Demaire Daniëlle Strens Georgi Nalbantov

Eur J Surg Oncol 2021 Feb 26. Epub 2021 Feb 26.

Health Economics & Outcome Research Team, Monitor Deloitte, Zaventem, Belgium.

Background: Locally advanced soft tissue sarcoma (STS) management may include neoadjuvant or adjuvant treatment by radiotherapy (RT), chemotherapy (CT) or chemoradiotherapy (CRT) followed by wide surgical excision. While pathological complete response (pCR) to preoperative treatment is prognostic for survival in osteosarcomas, its significance for STS is unclear. We aimed to evaluate the prognostic significance of pCR to pre-operative treatment on 3-year disease-free survival (3y-DFS) in STS patients. Read More

View Article and Full-Text PDF

February 2021

Similar Publications

Cardiac Resynchronization Therapy response assessment with electromechanical activation mapping within 24 hours of device implantation - a pilot study.

Authors:

Lea Melki Daniel Y Wang Christopher S Grubb Rachel Weber Angelo Biviano Elaine Y Wan Hasan Garan Elisa E Konofagou

J Am Soc Echocardiogr 2021 Mar 3. Epub 2021 Mar 3.

Ultrasound Elasticity Imaging Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY 10032, USA; Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address:

Background: Cardiac Resynchronization Therapy (CRT) response assessment relies on the QRS complex narrowing criterion. Yet, a third of patients do not improve despite narrowed QRS post-implantation. Electromechanical Wave Imaging (EWI) is a quantitative echocardiography-based technique capable of non-invasively mapping cardiac electromechanical activation in 3D. Read More

View Article and Full-Text PDF

March 2021

Similar Publications

Search Our Scientific Publications & Authors